Navigation Links
IVF Thanksgiving: Reproductive Science Center Marks 25th Anniversary
Date:11/25/2013

Boston, MA (PRWEB) November 25, 2013

RSC New England is celebrating its 25th anniversary year. But, most importantly, November marks the birth of the first baby conceived through in vitro fertilization (IVF) facilitated by the Reproductive Science Center’s fertility expert doctors and embryologists.

Looking back at the development of reproductive science, the first IVF baby, Louise Brown, was born in England in 1978. Biologist Dr. Robert Edwards and his colleague Obstetrician/Gynecologist Dr. Patrick Steptoe combined the eggs and sperm of Louise’s parents together in laboratory culture media to allow fertilization and embryo development to ensue – the process known as in vitro fertilization (IVF).

In 1986, the American Society for Reproductive Medicine (ASRM) formed the organization that would become the Society for Assisted Reproductive Technology (SART). This marked the recognition of assisted reproduction as an important and specific practice of reproductive medicine.

RSC New England opened in October 1988, began doing IVF cycles in January 1989, and in November 1989 achieved its first live birth. A member of ASRM and SART since their inception, the Reproductive Science Center has participated in developing the guidelines followed nationally by ASRM member fertility treatment doctors and centers. RSC New England has also achieved and/or introduced numerous advances in the practice of reproductive medicine and assisted reproductive technology.

In March 1994, RSC was among the first fertility centers to offer Intracytoplasmic Sperm Injection (ICSI), a laboratory procedure that isolates and injects one sperm into an egg, resulting in a high likelihood of fertilization and embryo development. Considered one of the sentinel achievements in reproductive technology, ICSI has revolutionized the treatment of male factor infertility.

In 1996, Reproductive Science Center physicians and embryologists achieved pregnancy for a couple challenged by a previously untreatable form of male factor infertility known as azoospermia, in which the man has no sperm in his ejaculate. The RSC doctors were able to use sperm, which had previously been frozen after being surgically retrieved from the man’s testicles. Using ICSI, his testicular sperm was injected into eggs retrieved from his wife. Embryos developed, leading to a successful pregnancy and live birth of a healthy baby.

In addition to ICSI, RSC was also an early adopter of Preimplantation Genetic Diagnostic testing (PGD), and more specifically “microarray” technology that affords a much higher sensitivity for genetic mutation detection or chromosome copy number determination in embryos. RSC Science and Laboratory Director Kathryn Go, PhD explains that, “The evolution of these methods is critically important in all areas of medicine and is widely applied to understand the differences between healthy and diseased cells and tissues.”

The 1990s also marked the emergence of “third party reproduction” -- the use of egg donors and gestational surrogates. These were critical in expanding services to older infertile women especially, as well as women who could not gestate (carry a pregnancy). IVF using egg donors and gestational carriers has also revolutionized the ability for male couples to have genetically related children. The Reproductive Science Center’s Medical Director, Samuel Pang, MD, was the first Reproductive Endocrinologist in New England to facilitate IVF for a gay male couple in 1998. Dr. Pang has also pioneered “Reciprocal IVF” for female couples in which one partner provides eggs and the other carries the pregnancy. (The center maintains GayIVF.com, a website dedicated to information about assisted reproduction options for gay, lesbian and transgender men and women.)

Most recently, RSC New England has begun using “vitrification”, a rapid freezing and advanced thawing technique that enables oocytes (eggs) to be preserved. Among other benefits, vitrification enables women with cancer to preserve their fertility. RSC has an urgent response team available specifically for cancer patients.

Vitrification also enables women who are not ready for pregnancy in their peak child-bearing years to preserve their fertility through egg freezing. Couples not ready for pregnancy can also go through IVF and preserve embryos using the rapid freezing technique.

In 2010, RSC opened MyEggBank at RSC New England, a program through which young healthy women donate their eggs to be frozen, stored in the Egg Bank and available for use by couples that can only achieve pregnancy using donor eggs. The MyEggBank network, of which RSC New England is a founding member, is the largest international frozen egg bank.

One of the largest and most experienced fertility treatment centers in the United States, the Reproductive Science Center of New England provides comprehensive diagnosis, evaluation, consultation and treatment for infertility. RSC New England has 11 locations in Massachusetts, New Hampshire and Rhode Island and is a partner member of IntegraMed Fertility, the most expansive network of infertility treatment centers and fertility specialist physicians in the nation.

Read the full story at http://www.prweb.com/releases/2013Thanksgiving/11IVF/prweb11361975.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Auxogyn And Reproductive Medicine Associates of New Jersey Partner To Advance in vitro fertilization Research
2. Reproductive Medicine Associates of New Jersey and Auxogyn Launch Fertility Study To Advance Goals of One Embryo, One Healthy Baby
3. New Egg Donation Program, "Ovatures," Launched By Reproductive Medicine Associates Of New Jersey
4. Reproductive Medicine Associates of New Jersey Receives ACOG Prize for Paper on SET and CCS, a Pioneering IVF Process
5. Center Of Reproductive Medicine Participates In The Thrive-IVF Research Study To Help Improve Pregnancy Success Rates And Outcomes In Women With A History Of Repeated In Vitro Fertilization (IVF) Failures
6. Garage Start-ups Now Possible in Life Sciences Industry
7. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
8. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
9. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
10. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
11. BioSpace Spotlights Northwests Life Science Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... of intellectual property, today provided an update on the ... District of Texas and announcing ... Inter Partes Re-examination ("IPR") proceedings that VTech and ... was initiated on only certain claims of two of ...
(Date:2/3/2016)... DIEGO , Feb. 3, 2016   ... company with the first pluripotent stem cell-derived islet ... diabetes in clinical-stage development, today announced that ViaCyte ... Pharmaceutical Companies of Johnson & Johnson, have agreed ... group into ViaCyte.  The agreement provides ViaCyte with ...
(Date:2/3/2016)... NEW BRUNSWICK, N.J. , Feb. 3, 2016 ... 30 grants totaling more than $1 million for ... who are working on health-related research that demonstrates ... , this round of funding for the New ... available for faculty members at these educational institutions— ...
(Date:2/3/2016)... Feb. 3, 2016  Silk Therapeutics, Inc., today announced the ... Therapeutics has now raised a total of $10.25 million in ... company. The Series A2 round was led by existing investor ... with participation from new investors Lear Corporation and Highland Consumer ... P. Disney ; Richard Sackler , MD, with Summer ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
Breaking Biology News(10 mins):